Bengaluru-based firm says 3D printed liver tissue developed

"Our 3D bio-printed mini-livers that mimic the human liver will serve as test platforms for discovery and development of drugs with better efficacy, less side effects and at lower costs," Pandorum co-founder Arun Chandru was reported as saying by ibtimes.com.

Usually, it requires millions of dollars spent over several years for a single new drug to come to the market.

Chandru said the tissue developed by his company would reduce both the cost and time taken for new drugs to be developed and tested.

Apart from clinical trials, the 3D printed tissue could be put to other uses as well.

"Development of artificial organs has numerous clinical uses. Cell based organoids can be used to develop bio-artificial liver support systems for preserving life in patients who have developed liver failure," said company co-founder Tuhin Bhowmick.

Bhowmick added that "in the near future, such artificial organs will address the acute shortage of human organs available for surgical transplantation".